FREDERICK G KUSHNER

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease MARRERO, LA NPI 1649236381

General Payments — all program years on this page

$72,359.16

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 100
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $10,040.50 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $9,750.001
Food and Beverage $290.5017

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $10,519.0026
2019 $13,784.4223
2020 $9,357.213
2021 $6,963.078
2022 $146.628
2023 $21,548.3414
2024 $10,040.5018

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078034016 Janssen Pharmaceuticals, Inc $24.19 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1081717134 Lexicon Pharmaceuticals, Inc. $25.38 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087042844 Novartis Pharmaceuticals Corporation $18.14 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087042846 Novartis Pharmaceuticals Corporation $20.72 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087042848 Novartis Pharmaceuticals Corporation $20.28 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087042850 Novartis Pharmaceuticals Corporation $14.25 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087042858 Novartis Pharmaceuticals Corporation $12.66 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087042860 Novartis Pharmaceuticals Corporation $12.84 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087042862 Novartis Pharmaceuticals Corporation $14.95 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087042870 Novartis Pharmaceuticals Corporation $13.23 08/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087042874 Novartis Pharmaceuticals Corporation $17.22 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087042876 Novartis Pharmaceuticals Corporation $4.20 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101517979 E.R. Squibb & Sons, L.L.C. $17.89 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104495056 AstraZeneca Pharmaceuticals LP $9,750.00 11/12/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1125832701 Alnylam Pharmaceuticals Inc. $25.30 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130883564 PFIZER INC. $16.16 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131237049 PFIZER INC. $16.22 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154050654 iRhythm Technologies, Inc. $16.87 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.